Jenene D. Thomas, Chief Executive Officer and Founder
Jenene Thomas brings an extensive network and expertise in investor relations and corporate communications in the biopharmaceutical industry, both in public and private companies, as evidenced by her successful track record with more than 15 years of creating and executing comprehensive, global communications programs and increasing corporate visibility among multiple key audiences including investors, potential partners and media.
Previously, Ms. Thomas served as Vice President of Investor Relations and Business Administration at Unigene Laboratories and as Director, Investor Relations and Corporate Communications at Amicus Therapeutics. Prior to Amicus, she was the CEO and President of JDT Communications where she provided investor relations and corporate communications counsel and created fully integrated communications plans for clients which include, Enzon Pharmaceuticals and Regado Biosciences. She also served as Senior Director, Investor Relations and Corporate Communications at Aeterna Zentaris. As the company’s first U.S. employee, Ms. Thomas rapidly established broad awareness in the U.S. with analysts and other stakeholders in the financial community. She also held investor relations positions of increasing responsibility at Savient Pharmaceuticals, Reliant Pharmaceuticals and Pharmacia Corporation.
Justin E. Romanowski, Vice President
Mr. Romanowski has served as Vice President since April 2014. Prior to joining Jenene Thomas Communications, he was Associate Director, Business Development for Enteris BioPharma, Inc., where he led out-licensing efforts for the company’s novel oral drug delivery platform and was also responsible for branding the company and developing a robust marketing strategy during Enteris’ formation. Prior to Enteris, Mr. Romanowski was Associate Director, Business Development of Unigene Laboratories, Inc. While serving at Unigene in positions of increasing responsibility, he supported the development and execution of a turnaround business development and investor relations strategy under the newly formed management team. Mr. Romanowski has a Bachelor’s degree in Finance from Rider University.